PLoS ONE (Jan 2018)
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0198389.].
PLoS ONE (Jan 2018)
[This corrects the article DOI: 10.1371/journal.pone.0198389.].